USC News

Menu Wednesday, January 29, 2020 53° Clear


CAR T-cell therapy
This colored scanning electron micrograph shows a T cell (red) attached to a cancer cell. CAR T-cell therapy involves harvesting T-cells from a patient, reengineering them in the lab to target a particular kind of cancer, then reinfusing them into the patient. (Image/Steve Gschmeissner, Science Source)

USC-led advance in groundbreaking cancer treatment eliminates severe side effects

Though the study was designed to assess safety, six out of 11 lymphoma patients who received a commonly used dose of the improved CAR T-cell therapy went into complete remission.

Illustration: Cancer's circadian clock
A new drug appears to stop cancer by jamming the circadian rhythm of cancer cells. Scientists say this promising treatment hindered the growth of different types of cancer in their lab and mouse studies, including bone cancer, acute myeloid leukemia and kidney cancer. (Illustration/Dennis Lan, iStock)

New drug may slow cancer’s circadian clock, halts its spread

USC scientists know that disrupting sleep and other elements of humans’ circadian rhythm can harm health. The same may be true for the circadian clock of cells themselves.